Aude Ouensanga

Boston, USA

Aude advises start-ups and large global corporations in the U.S., EU, and Japan. Since joining Alira Health in 2012, Aude has managed over 100 corporate strategy, commercial due diligence, pre-commercial value assessments, and M&A projects in MedTech and Pharma. Previously, Aude was as an M&A analyst at BNP Paribas and a strategy analyst at Novartis Pharma. A registered U.S. investment banker with FINRA Series 79 and 63 certifications, Aude also manages Alira Health Ventures companies.


Speaking engagements icon
of speaking engagements/year
Years in industry icon
of years in the industry
Projects completed
of projects completed

Key areas of expertise

  • Drug Delivery Systems and Medical Contract Manufacturing
  • Infection Prevention
  • Wound Care
  • Digital Health
  • AI in Drug Discovery
  • Biopharmaceutical Assets and Pre-commercial Value Assessments

Languages spoken

United Kingdom flag icon English
French flag icon French

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.